Pharmafile Logo
Pharmafocus logo
Advanced Search

Sales and Marketing

Showing 15 posts of 11528 posts found.

Allergan bolsters skincare portfolio with Elastagen acquisition for $95 million

February 7, 2018 Research and Development, Sales and Marketing Allergan, Elastagen, M&A, MA, pharma

Pharma’s M&A train keeps on going as news breaks that Allergan has picked up University of Sydney spin-off Elastagen for …
News

Allergan successfully concludes CFO search

February 6, 2018 Business Services, Manufacturing and Production, Medical Communications, Research and Development, Sales and Marketing Allergan, biotech, drugs, pharma, pharmaceutical

Allergan has been searching for a new Chief Financial Officer since Tessa Hilado, its current CFO, revealed that she would …
Appointment

PTx picks up radiation drug and plant from Sanofi

February 6, 2018 Manufacturing and Production, Sales and Marketing Partnership Therapeutics, Sanofi, biotech, drugs, pharma, pharmaceutical

A Boston-based biotech, only a few weeks old, has moved quickly to secure both the drug Leukine and the plant …
News

The future is now: The transformative power of AI

February 5, 2018 Business Services, Manufacturing and Production, Medical Communications, Research and Development, Sales and Marketing AI, Exscientia, GSK, GlaxoSmithKline, artificial intelligence, drug development, pharma

With the technologies reaching exciting levels of maturity and adoption, Matt Fellows investigates how AI and machine learning can be …
Feature

Rapidly-growing Nektar Therapeutics reportedly considering sale of its business

February 5, 2018 Manufacturing and Production, Sales and Marketing M&A, MA, Nektar, Nektar Therapeutics, acquisition, pharma

After a slew of M&A deals throughout the first month of 2018, including Celgene’s buyout of Juno Therapeutics for $9 …
News

UK GPs are “undervalued” with 40% looking to quit profession, study finds

February 5, 2018 Medical Communications, Sales and Marketing GPs, NHS, UK, health, pharma

Falling numbers of General Practitioners (GPs) in the UK are due to “concerns regarding professional risk in delivering care in …
News

UK breast cancer mortality falls 10% over five years, overtaken by prostate deaths for first time

February 5, 2018 Research and Development, Sales and Marketing Cancer, Cancer Research UK, breast cancer, pharma, prostate cancer

Breast cancer deaths in the UK have fallen by 10% in the past five years, according to research released by …
News

Philippines’ launches legal action after Sanofi refuses to refund over dengue vaccine damages

February 5, 2018 Sales and Marketing Philippines, Sanofi, dengue, dengvaxia, pharma

Sanofi has refused both requests from the Government of the Philippines to refund used doses of its Dengvaxia vaccine as …
News

64% of FDC antibiotics in India are unapproved, report reveals

February 5, 2018 Manufacturing and Production, Sales and Marketing Antibiotics, India, antimicrobial resistance, pharma

The majority of fixed dose combination (FDC) antibiotics that are made and sold in India are still unapproved, despite promises …
News

Top Ten most popular articles on Pharmafile.com this week

February 2, 2018 Business Services, Manufacturing and Production, Medical Communications, Research and Development, Sales and Marketing Ablynx, Alzheimer's, Apotex, AstraZeneca, Brexit Health Alliance, CDC, Duchenne Muscular Dystrophy, EMA, Italy, Sanofi, amazon, brexit, santhera, top ten

It’s the first Friday of February, and it’s time for another recap of the top ten articles most popular with …
News

Faslodex rejected by NICE for NHS breast cancer use

February 2, 2018 Research and Development, Sales and Marketing AstraZeneca, Faslodex, NHS, NICE, UK, pharma

Bad news for breast cancer patients in the UK as the National Institute for Health and Care Excellence announces it …
News

Array BioPharma demands $192m after AstraZeneca refuses to pay royalties

February 2, 2018 Medical Communications, Sales and Marketing Array Biopharma, AstraZeneca, lawsuit, selemetinib

Array BioPharma has launched a lawsuit against AstraZeneca over allegations the latter has refused to pay royalties it owes for …
News

Allergan’s Avycaz becomes first FDA-approved gram-negative antibiotic in over 15 years

February 2, 2018 Medical Communications, Sales and Marketing Allergan, Avycaz, FDA, pharma, pneumonia

Allergan has announced that the FDA has awarded approval to its fixed-dose combination antibacterial Avycaaz (ceftazidme and avibactam) for the …
News

Working Life: Marco Avila, Vice President of Medical Affairs, Teva Europe

February 1, 2018 Business Services, Manufacturing and Production, Medical Communications, Research and Development, Sales and Marketing Teva, Working Life

Pharmafile.com met with Marco Avila, Vice President of Medical Affairs at Teva Europe to discuss his life in the industry, …
Feature

NICE approves Perjeta for routine use on NHS

February 1, 2018 Sales and Marketing Perjeta, Roche, biotech, drugs, pharma, pharmaceutical

NICE has given the nod to Roche’s Perjeta for routine first-line use, alongside Herceptin and chemotherapy, in patients with HER2-positive …
News
The Gateway to Local Adoption Series

Latest content

From lab breakthrough to NHS treatment: Getting innovative therapies to patients

September 5, 2026

Five Facts about NHS and primary care

September 5, 2026

Clinical trials don’t just have a recruitment problem, they have an enrolment protection problem.

September 5, 2026

AI in pharma: From lab development to patient impact

September 5, 2026

Back to basics: X-ray inspection in pharmaceutical and medical device production

September 5, 2026